Human Kv7.2/Kv7.4 Potassium Channel Cell Line

Double click on above image to view full picture

Zoom Out
Zoom In

More Views

  • Flupirtine potentiation of hKv7.2/hKv7.4 channel currents recorded by QPatch HT™.
  • Time course of flupirtine-induced changes in current amplitude. Recording instrument: QPatch HT™.

Human Kv7.2/Kv7.4 Potassium Channel Cell Line

  • Cat.#:
  • CT6148

Availability: In stock

Call 216.332.1665 or email
inquiries@chantest.com
for pricing
OR

Quick Overview

Human Kv7.2/Kv7.4 potassium ion channel-expressing, stable replicating cell line.

Background

The human KCNQ2 and KCNQ4 genes encode the pore-forming subunits of Kv7.2 and Kv7.4, respectively. These subunits form heteromeric voltage-gated potassium channels that underlie M-current that regulates repetitive activity in neurons. Mutations in KCNQ2 that reduce M-current are responsible for some forms of benign familial neonatal seizure. KCNQ4 loss-of-function mutations cause hereditary deafness. Kv7.2/Kv7.4 channels are therapeutic targets in seizure and neuropathic pain.
General Info
Synonyms KCNQ2/KCNQ4
Product Description Human Kv7.2/Kv7.4 potassium ion channel-expressing, stable replicating cell line.
Target Type Ion Channel
Product Type Replicating Cell Line
Family Potassium, Voltage-Gated
Sub-Type Kv7.2/Kv7.4
Class Voltage-gated potassium channel
Therapeutic Area pain & inflammation, seizure-convulsion
Related Services Large-scale Cryopreservation
Gene Name KCNQ2/KCNQ4
Validated Assay/Platform PatchXpress®
References Gutman GA, et al. 2005. Pharmacol Rev. 57:473-508. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels.
Host cell CHO
Mycoplasma Status Negative (MycoAlert Kit)
Storage & Packaging
Packaging Cryopreserved cells, 1-2x106 cells
Storage Recommendation liquid nitrogen
Quantity 1-2 million cells
Product Documentation
Specification Sheet  Download PDF Document